Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subantimicrobial dose doxycycline in mild Thyroid-Associated Ophthalmopathy
NCT02203682Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2014
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in thyroid associated ophthalmopathy (TAO), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
doxycycline
03
Conditions
thyroid associated ophthalmopathy (TAO)
Beyond the preview
Go deeper on NCT02203682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02203682.